$ZVRA
Zevra Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Boston, MA
ZVRA chart
What traders are saying about $ZVRA
Latest postsZevra Therapeutics, Inc. news
- Wall Street Analysts Believe Zevra Therapeutics (ZVRA) Could Rally 117.86%: Here's is How to Trade
Yahoo Finance ·
- ZVRA News | ZEVRA THERAPEUTICS INC (NASDAQ:ZVRA)
ChartMill ·
- ZEVRA THERAPEUTICS INC (ZVRA) Stock Chart
ChartMill ·
- Zevra Therapeutics, Inc. (ZVRA) Seasonal returns chart
Yahoo Finance UK ·
- Zevra Therapeutics, Inc. Just Beat EPS By 69%: Here's What Analysts Think Will Happen Next
Simply Wall St ·
- BTIG Maintains Zevra Therapeutics(ZVRA.US) With Buy Rating, Maintains Target Price $24
Moomoo ·
- Fidelity Contrafund holds 5.6% of Zevra (ZVRA); FMR also reports a stake.
Stock Titan ·
- Zevra (ZVRA) Q3 2026 Earnings Call Transcript
fool.com ·
- What Pushed Zevra Therapeutics (NASDAQ:ZVRA) to USD 19.2 Million of Net Income This Quarter?
kalkine.ca ·
- Zevra Therapeutics, Inc. Q3 2026 Earnings Call Summary
app.moby.co ·
- Zevra Therapeutics (NASDAQ:ZVRA) Clears All Eight Growth Rules
ChartMill ·
- Zevra Therapeutics Inc (ZVRA) (Q3 2026) Earnings Call Highlights: Revenue Jumps 45% as MIPLYFFA ...
Yahoo Finance ·
Zevra Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | $83.2M | -$105.5M | -$46.0M | -$26.8M |
| Diluted EPS | $1.35 | $-2.28 | – | – |
| Total assets (year end) | $284.7M | $178.1M | $172.3M | $115.3M |
| Cash and equivalents (year end) | $62.4M | $33.8M | $43.0M | $65.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Zevra Therapeutics, Inc.
- Ticker
- ZVRA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1434647
- Former names
- KEMPHARM, INC, KEMPHARM INC
Frequently asked questions
What exchange is Zevra Therapeutics, Inc. listed on?
Zevra Therapeutics, Inc. trades on the Nasdaq under the ticker symbol ZVRA.
What industry is Zevra Therapeutics, Inc. in?
Zevra Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Zevra Therapeutics, Inc. headquartered?
Zevra Therapeutics, Inc.'s business address on file with the SEC is in Boston, MA.
When does Zevra Therapeutics, Inc.'s fiscal year end?
Zevra Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Zevra Therapeutics, Inc. report?
Zevra Therapeutics, Inc. reported $0 in revenue for calendar year 2015, according to its SEC filings.